We then selected two NSCLC lines (H1975 and LC-KJ) that showed high KYNU transcript levels and used siRNA to knockdown either QPRT, which catalyzes the final step of the de novo pathway, or KYNU itself. Here, QPRT is linked to non-small cell lung carcinoma.